Metagenomi finds novel gene-editing tools by mining microbial samples from around the world. Already partnered with Moderna and Ionis Pharmaceuticals, the company said its IPO cash will support ongoing preclinical research.
Moderna & Ionis-Partnered Biotech Lands $94M in IPO Cash for Gene-Editing R&D
